Lineage Cell Therapeutics Inc (STU:BT3) Stock News, Headlines & Updates
Lineage Cell Therapeutics Inc Stock News from GuruFocus
- 1
Jul 24, 2025
BlackRock, Inc. Significantly Reduces Holdings in Lineage Cell Therapeutics Inc
GuruFocus News • 8:49pm
Jun 23, 2025
Lineage Cell Therapeutics (LCTX) Receives Continued 'Buy' Rating from Analyst | LCTX Stock News
GuruFocus News • 9:00am
Lineage Cell Therapeutics (LCTX): Analyst Reiterates Buy Rating | LCTX Stock News
GuruFocus News • 7:00am
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025 | LCTX Stock News
GuruFocus News • 6:20am
May 14, 2025
Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC | LCTX Stock News
GuruFocus News • 7:22am
Lineage Cell Therapeutics Inc (LCTX) Q1 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience
GuruFocus News • 1:14am
Q1 2025 Lineage Cell Therapeutics Inc Earnings Call Transcript
GuruFocus News • 11:08pm
May 13, 2025
Lineage Cell Therapeutics Q1 2025 Earnings: EPS Beats Estimates at -$0.02, Revenue Misses at $1.5 Million
GuruFocus News • 3:36pm
May 01, 2025
BlackRock, Inc.'s Strategic Acquisition of Lineage Cell Therapeutics Inc Shares
GuruFocus News • 7:34pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news